Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2016 1
2017 2
2018 2
2019 5
2020 3
2021 2
2022 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ferdowsi n
Search for Ferdowsh N instead (1 results)
Measures of disease status in systemic sclerosis: A systematic review.
Tay T, Ferdowsi N, Baron M, Stevens W, Hudson M, Proudman SM, Nikpour M; Damage Index Working Group of the Scleroderma Clinical Trials Consortium. Tay T, et al. Among authors: ferdowsi n. Semin Arthritis Rheum. 2017 Feb;46(4):473-487. doi: 10.1016/j.semarthrit.2016.07.010. Epub 2016 Jul 29. Semin Arthritis Rheum. 2017. PMID: 27765344 Review.
Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease.
Fairley JL, Ross L, Burns A, Prior D, Conron M, Rouse H, McDonald J, MacIsaac A, La Gerche A, Morrisroe K, Ferdowsi N, Quinlivan A, Brown Z, Stevens W, Nikpour M. Fairley JL, et al. Among authors: ferdowsi n. Intern Med J. 2023 Oct;53(10):1919-1924. doi: 10.1111/imj.16233. Epub 2023 Sep 29. Intern Med J. 2023. PMID: 37772776 Free PMC article. Review.
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL, Hansen D, Ross L, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Apostolopoulous D, Ferdowsi N, Wilson M, Tabesh M, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Fairley JL, et al. Among authors: ferdowsi n. Arthritis Res Ther. 2023 May 12;25(1):77. doi: 10.1186/s13075-023-03059-x. Arthritis Res Ther. 2023. PMID: 37173780 Free PMC article.
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group. Ferdowsi N, et al. Ann Rheum Dis. 2019 Jun;78(6):807-816. doi: 10.1136/annrheumdis-2018-214764. Epub 2019 Mar 30. Ann Rheum Dis. 2019. PMID: 30928903
Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling.
Barbacki A, Baron M, Wang M, Zhang Y, Stevens W, Sahhar J, Proudman S, Nikpour M, Man A; Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group. Barbacki A, et al. Arthritis Care Res (Hoboken). 2023 Mar;75(3):640-647. doi: 10.1002/acr.24873. Epub 2022 Nov 15. Arthritis Care Res (Hoboken). 2023. PMID: 35226416
Occupational silica exposure in an Australian systemic sclerosis cohort.
Patel S, Morrisroe K, Proudman S, Hansen D, Sahhar J, Sim MR, Ngian GS, Walker J, Strickland G, Wilson M, Ferdowsi N, Major G, Roddy J, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Patel S, et al. Among authors: ferdowsi n. Rheumatology (Oxford). 2020 Dec 1;59(12):3900-3905. doi: 10.1093/rheumatology/keaa446. Rheumatology (Oxford). 2020. PMID: 32911541
Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis.
Morrisroe K, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS, Ferdowsi N, Hill C, Roddy J, Walker J, Proudman S, Nikpour M. Morrisroe K, et al. Among authors: ferdowsi n. Arthritis Care Res (Hoboken). 2020 Nov;72(11):1625-1635. doi: 10.1002/acr.24076. Arthritis Care Res (Hoboken). 2020. PMID: 31539207
Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.
Hoa S, Bernatsky S, Baron M, Proudman S, Stevens W, Sahhar J, Wang M, Steele RJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Nikpour M, Hudson M. Hoa S, et al. Chest. 2021 Dec;160(6):2158-2162. doi: 10.1016/j.chest.2021.06.014. Epub 2021 Jun 18. Chest. 2021. PMID: 34153341 No abstract available.
Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Walker J, Strickland G, Wilson M, Morrisroe K, Ferdowsi N, Major G, Roddy J, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Fairley JL, et al. Among authors: ferdowsi n. Arthritis Care Res (Hoboken). 2021 May;73(5):732-741. doi: 10.1002/acr.24167. Epub 2021 Apr 3. Arthritis Care Res (Hoboken). 2021. PMID: 32058672
23 results